Neogenomics (NEO) Restructuring Costs (2022 - 2024)

Neogenomics has reported Restructuring Costs for 3 years, with the latest figure at $2.4 million in Q1 2024.

• For the quarter ending Q1 2024, Restructuring Costs fell 48.8% year-over-year to $2.4 million; the trailing twelve-month figure through Mar 2024 stood at $8.8 million (down 4.33% YoY), and the FY2024 full-year result was $6.7 million, down 39.95% from the prior year.
• Restructuring Costs for Q1 2024 stood at $2.4 million, up from $1.2 million in the prior quarter.
• The five-year high for Restructuring Costs was $4.7 million in Q1 2023, with the low at $1.2 million in Q4 2023.
• Historically, Restructuring Costs has averaged $3.0 million across 3 years, with a median of $2.7 million in 2023.
• Annual changes were most pronounced in 2023 — Restructuring Costs sank 73.32% — and 2024, when it slumped 48.8%.
• Neogenomics' Restructuring Costs stood at $4.5 million in 2022, then slumped by 73.32% to $1.2 million in 2023, then soared by 99.0% to $2.4 million in 2024.
• The last three Restructuring Costs figures came in at $2.4 million (Q1 2024), $1.2 million (Q4 2023), and $2.1 million (Q3 2023), per Business Quant data.